Choosing a dietary supplement manufacturer is a decision most brand owners only make a handful of times, while the manufacturers themselves are evaluated by hundreds of prospective clients every year. That asymmetry matters — it means the burden of due diligence sits almost entirely on the buyer, and a rushed evaluation tends to surface problems only after production has already started, when they’re far more expensive to fix.
This is a structured framework for evaluating a potential manufacturing partner, organized around the areas that actually predict whether a relationship works.
Pillar 1: Regulatory Standing
This is the non-negotiable starting point, and it should be verified, not taken on faith.
- FDA Food Facility Registration. Every facility manufacturing, processing, packing, or holding dietary supplements for U.S. distribution must maintain active FDA registration. Ask for the registration number and confirm its status directly rather than accepting a claim at face value.
- Independent third-party cGMP certification. There’s a meaningful difference between a manufacturer that says it follows cGMP practices and one that has been independently audited and certified against 21 CFR Part 111 by an accredited third-party certification body. Ask who issued the certification, what accreditation body stands behind that certifier, and what the certification’s exact scope covers — capsule, powder, and tablet operations often have different certified scopes within the same facility.
- State-level registration, where applicable. Some states, including California, require their own processed food manufacturing registration in addition to federal requirements. A manufacturer operating in such a state should hold both.
Jump to view our certification page
Pillar 2: Documentation and Traceability
A manufacturer’s paperwork discipline is one of the most reliable predictors of its production discipline.
- Batch production records. Ask to see a sample (redacted, if needed for confidentiality) of what a completed batch record looks like. Under cGMP, an undocumented step is treated as one that never happened — a manufacturer that can’t produce clean, complete batch records for past production has almost certainly cut corners on production itself.
- Certificates of Analysis (COAs). Every finished batch should have a COA confirming it passed the specified testing. Ask whether COAs are generated in-house, by a third-party lab, or both.
- Raw material testing records. Identity, potency, heavy metal, and microbiological testing on incoming raw materials should be standard, not an add-on service. Ask specifically what percentage of incoming lots are tested and by whom.
Pillar 3: Production Capability and Capacity
- Actual in-house capability versus brokered production. Some manufacturers produce everything they offer in-house; others handle certain formats or ingredients directly and coordinate others through partner facilities. Neither approach is inherently wrong, but you should know which is which for any specific product you’re planning, since it affects lead times, quality oversight, and who’s accountable if something goes wrong.
- Minimum order quantities and scalability. Confirm MOQs match your current stage, and ask what the path looks like if you need to scale from a pilot run to a much larger production volume later.
- Realistic lead times. Ask for a lead time estimate tied to a specific, realistic scenario (your actual formula and format), not a generic marketing claim. Confirm whether that estimate starts from raw material arrival or from order placement — these can differ by several weeks.
Pillar 4: Formulation and R&D Support
- Private label versus custom formulation capability. Confirm the manufacturer genuinely supports both paths, not just one dressed up as the other. If a “custom formulation” is really just a minor tweak to an existing base formula, that’s worth knowing upfront.
- Stability and compatibility testing. For any custom formula, ask how the manufacturer validates that the finished product remains stable and effective through its intended shelf life, not just at the moment of production.
- Regulatory awareness for the specific ingredients you’re using. Some ingredients carry more regulatory complexity than others — a manufacturer that can speak knowledgeably about the current legal and labeling status of your specific ingredients is a meaningfully safer partner than one treating every ingredient identically.
Jump to view our comprehensive services
Pillar 5: Communication and Accountability
- A named point of contact, not a rotating queue of whoever answers the phone that day.
- Clear escalation path for quality issues, delays, or order changes — ask what happens, concretely, if a batch fails quality testing.
- References from existing clients, ideally brands of a similar size and category to yours, who can speak to real experience rather than a curated testimonial.
Red Flags Worth Taking Seriously
Most of due diligence is about confirming positives, but a few specific warning signs deserve extra weight if you encounter them:
- Reluctance to name the actual certifying body. “We’re cGMP compliant” without a specific third-party certifier and accreditation body attached is a claim, not a credential. A manufacturer that gets vague or defensive when asked “certified by whom, exactly?” is telling you something.
- A quote that arrives before you’ve described your formula. Pricing that doesn’t vary based on ingredient complexity, batch size, or testing requirements suggests a manufacturer working from a generic template rather than actually evaluating your specific product.
- No sample batch record or COA available on request. If a manufacturer can’t produce an example of its own documentation — even a redacted one — that’s a meaningful gap, not a confidentiality technicality.
- Every question gets answered with “don’t worry about that.” Reasonable manufacturers explain their processes. Evasiveness about specifics, especially around testing and sourcing, tends to compound into bigger problems once you’re under contract.
- Unusually short, generic answers about raw material sourcing. “We use quality suppliers” isn’t an answer. A manufacturer that can’t describe how it qualifies and tests incoming raw materials likely doesn’t have a rigorous process for doing so.
- Pressure to commit before you’ve seen documentation. Urgency (“this pricing is only good today”) aimed at getting a signature before due diligence is complete is a sales tactic, not a business practice a serious long-term partner needs to rely on.
None of these, on their own, are necessarily disqualifying — but more than one showing up in the same evaluation is a pattern worth taking seriously.
What a Realistic First-Order Timeline Looks Like
Due diligence doesn’t end when you sign — it continues, in a different form, through your first production run. A realistic timeline for a first private label order looks something like this:
- Initial evaluation and documentation review (1–3 weeks) — the due diligence process outlined above.
- Formula selection or finalization (days to a few weeks for private label; often 6–10 weeks for a custom formulation, including stability testing) — this is where you confirm exact specifications, not just a general category.
- Sample or pilot batch (varies by manufacturer) — many manufacturers will run a small sample batch before committing to full production, giving you a chance to review the actual finished product, not just a formula on paper.
- Packaging and labeling finalization — label copy, artwork, and compliance review should be locked before production begins, not adjusted mid-run.
- Full production run (commonly 4–8 weeks once raw materials and packaging have arrived at the facility, though this varies significantly by manufacturer and order complexity).
- Quality release and COA delivery — finished product shouldn’t ship until it has cleared the manufacturer’s own release testing, with COA documentation provided alongside the shipment.
Knowing this sequence in advance makes it much easier to spot a manufacturer whose actual process is vaguer or less structured than they initially represent.
Frequently Asked Questions
How long should the vetting process take?
For a straightforward private label product, a few weeks of evaluation is typically reasonable. For a custom formulation or a larger production commitment, plan for longer — rushing this stage is one of the most common, avoidable causes of problems later.
Should I request a facility tour?
Yes, if at all practical. A manufacturer confident in its operations should welcome this. If a facility consistently avoids or delays tour requests without a reasonable explanation, treat that as a signal worth taking seriously.
What documentation should I ask for before signing anything?
At minimum: current FDA registration confirmation, the cGMP certification itself (not just a logo on a website), and a sample batch record or COA format. A manufacturer with nothing to hide will provide these without friction.
Is a lower price ever a red flag?
Not automatically, but it’s worth understanding why a quote is lower than others you’ve received. Sometimes it reflects genuine efficiency; sometimes it reflects a shortcut somewhere in testing, documentation, or raw material sourcing that isn’t visible in the quote itself.
Can I switch manufacturers mid-product-line without starting over?
Generally yes, though it requires transferring or redeveloping the formula, updating documentation, and possibly requalifying packaging specs. It’s more disruptive than switching from the start, which is part of why the initial vetting process is worth doing carefully.
What’s the difference between a manufacturer and a broker?
A manufacturer produces at its own facility, under its own regulatory registrations. A broker coordinates production at other facilities on your behalf without necessarily disclosing that arrangement. Neither is illegitimate, but you should know which one you’re actually working with, since it affects accountability if something goes wrong.
Do I need a lawyer to review a manufacturing agreement?
For a first private label order, often not strictly necessary if the terms are standard and clearly written. For a custom formulation involving proprietary IP, exclusivity terms, or a significant financial commitment, having counsel review the agreement is a reasonable and common precaution.
What happens if a batch fails quality testing after production?
A manufacturer with real quality control should have a defined process for this — typically involving root-cause investigation, a corrective action plan, and either a rework or a replacement batch at no cost to you if the failure was on the manufacturer’s side. Ask about this scenario directly during evaluation, before you need the answer in an actual crisis.
Should I expect to own the formula, or does the manufacturer retain rights to it?
This depends entirely on the model. Private label formulas typically remain the manufacturer’s, available to other brands as well. Custom formulations should be addressed explicitly in your agreement — exclusivity, ownership, and whether the manufacturer can offer a similar formula to a competing brand are all terms worth negotiating clearly upfront, not assuming.
How do I evaluate a manufacturer’s raw material supply chain without visiting every supplier myself?
You can’t practically audit every supplier directly, which is exactly why the manufacturer’s own raw material testing program matters so much — identity, potency, and contaminant testing on every incoming lot is what stands between you and a supply chain issue you’d otherwise have no visibility into. Ask to see this program described in specific, verifiable terms rather than taking “we vet our suppliers” as a sufficient answer.
Working With a Manufacturer Built for Scrutiny
Ekang Nutra is a California-based, FDA-registered, cGMP-certified (independently certified by Eurofins Healthcare Assurance, accredited by ANAB under ISO/IEC 17065) dietary supplement manufacturer. We welcome due diligence — facility tours, documentation review, and direct conversations about exactly what our certification covers and what it doesn’t. We manufacture in hard capsules and powders, with tablet packaging and labeling, and full raw material identity and potency testing on every incoming lot.
Ready to start your evaluation? Contact our team — we’ll answer every question on this checklist directly.
